Homepage2607 • HKG
add
Shanghai Pharmaceuticals Holding Co Ltd
Vorige slotkoers
$Â 11,32
Dag-range
$Â 11,34 - $Â 11,62
Jaar-range
$Â 10,18 - $Â 16,60
Beurswaarde
64,82Â mld. HKD
Gem. volume
2,79Â mln.
Koers/winst
10,39
Dividendrendement
-
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | dec 2023info | Wijziging j-o-j |
---|---|---|
Opbrengst | 62,79Â mld. | 9,44% |
Bedrijfskosten | 5,80Â mld. | -6,15% |
Netto inkomsten | -28,77Â mln. | -103,58% |
Netto winstmarge | -0,05 | -103,57% |
Winst per aandeel | — | — |
EBITDA | 1,50Â mld. | -21,00% |
Effectief belastingtarief | 60,25% | — |
Balans
Totale activa
Totale passiva
(CNY) | dec 2023info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 40,67Â mld. | 9,87% |
Totale activa | 211,97Â mld. | 6,98% |
Totale passiva | 131,65Â mld. | 9,58% |
Totaal aandelenvermogen | 80,33 mld. | — |
Uitstaande aandelen | 3,70 mld. | — |
Koers-boekwaardeverhouding | 0,61 | — |
Rendement op activa | 1,37% | — |
Rendement op kapitaal | 2,19% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | dec 2023info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -28,77Â mln. | -103,58% |
Operationele kasstroom | 2,93Â mld. | -40,25% |
Kasstroom uit beleggingen | 507,68Â mln. | -68,49% |
Kasstroom uit financiering | -2,56Â mld. | 48,89% |
Nettomutatie in liquide middelen | 927,91Â mln. | -36,51% |
Vrije kasstroom | 3,92Â mld. | -32,87% |
Over
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Opgericht
18 jan 1994
Website
Werknemers
48.164